Ecopharmacovigilance is a crucial aspect of pharmacology that delves into the environmental impact of pharmaceutical substances, specifically focusing on their pharmacodynamics. Pharmacodynamics involves the study of how drugs interact with the body and the subsequent biological responses. In the context of ecopharmacovigilance, it extends beyond human health to assess the effects of pharmaceuticals on ecosystems and wildlife. Understanding the pharmacodynamics of drugs in the environment is vital for evaluating potential ecological risks. It encompasses the examination of how drugs persist, transform, and exert their effects in various environmental compartments. This field explores the intricate interplay between pharmaceuticals and non-target organisms, assessing both short-term and long-term impacts on biodiversity and ecosystem functioning. By scrutinizing pharmacodynamic aspects, ecopharmacovigilance aims to identify potential hazards posed by pharmaceutical residues in the environment and develop strategies to mitigate adverse effects. This involves comprehensive research to comprehend the fate of drugs in environmental matrices, their bioaccumulation, and potential consequences for ecosystems. Ultimately, integrating pharmacodynamics into ecopharmacovigilance practices ensures a holistic approach to pharmaceutical safety, addressing concerns beyond human health to safeguard the delicate balance of our ecosystems.
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : A NAMs-compatible mechanopharmacological model of drug penetration in the urinary bladder
Kunal Sharma, Swisss Federal Institute of Technology Lausanne, Switzerland
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Integrated Raman, SERS and computational approaches for the study of bioactive molecules in pharmaceutical chemistry
Maria Cristina Gamberini, University of Modena and Reggio Emilia, Italy
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada